UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 373

Sortiert nach

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

PloS one, 2015-03, Vol.10 (3), p.e0118564

2015

Volltextzugriff (PDF)

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance

PloS one, 2011, Vol.6 (8), p.e23429

2011

Volltextzugriff (PDF)

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

European journal of nuclear medicine and molecular imaging, 2018-01, Vol.45 (1), p.95-101

2018

Volltextzugriff (PDF)

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

PloS one, 2019-08, Vol.14 (8), p.e0221301-e0221301

2019

Volltextzugriff (PDF)

Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach

European journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2313-2321

2020

Volltextzugriff (PDF)

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

PloS one, 2013-11, Vol.8 (11), p.e81624-e81624

2013

Volltextzugriff (PDF)

Micrographic Surgery Allows Fascia Preservation in Dermatofibrosarcoma Protuberans

Acta dermato-venereologica, 2021-09, Vol.101 (9), p.adv00561-adv00561

2021

Volltextzugriff (PDF)

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Cancers, 2020-06, Vol.12 (7), p.1727

2020

Volltextzugriff (PDF)

Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome

PloS one, 2011-04, Vol.6 (4), p.e18397-e18397

2011

Volltextzugriff (PDF)

Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma

PloS one, 2014-01, Vol.9 (1), p.e86194-e86194

2014

Volltextzugriff (PDF)

Epidemiology of skin cancer

Advances in experimental medicine and biology, 2014, Vol.810, p.120

2014

Volltextzugriff (PDF)

Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma

PloS one, 2014-11, Vol.9 (11), p.e112535-e112535

2014

Volltextzugriff (PDF)

Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma

PloS one, 2017-11, Vol.12 (11), p.e0188602-e0188602

2017

Volltextzugriff (PDF)

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

PloS one, 2015-10, Vol.10 (10), p.e0139438-e0139438

2015

Volltextzugriff (PDF)

BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy

PloS one, 2014-02, Vol.9 (2), p.e89218

2014

Volltextzugriff (PDF)

Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial

Journal of clinical oncology, 2010-02, Vol.28 (5), p.841-846

2010

Volltextzugriff (PDF)

Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis

PloS one, 2013-04, Vol.8 (4), p.e63137-e63137

2013

Volltextzugriff (PDF)

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2019-04, Vol.19 (1), p.366-366, Article 366

2019

Volltextzugriff (PDF)

Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour

PloS one, 2013-06, Vol.8 (6), p.e66953-e66953

2013

Volltextzugriff (PDF)

Neuerungen in der aktualisierten S3-Leitlinie „Aktinische Keratosen und Plattenepithelkarzinom der Haut

Forum (Heidelberg), 2024-06, Vol.39 (3), p.166-169

2024

Volltextzugriff (PDF)

Sentinel Lymph Node Dissection in Primary Melanoma Reduces Subsequent Regional Lymph Node Metastasis as Well as Distant Metastasis After Nodal Involvement

Annals of surgical oncology, 2010-01, Vol.17 (1), p.129-137

2010

Volltextzugriff (PDF)

A novel role for relaxin-2 in the pathogenesis of primary varicosis

PloS one, 2012-06, Vol.7 (6), p.e39021-e39021

2012

Volltextzugriff (PDF)

Melanom der Haut – Fakten und Irrtümer: Damit die Haut beim Sonnen nicht Baden geht

CME (Berlin, Germany), 2015-04, Vol.12 (4), p.47-55

Garbe, Claus

2015

Volltextzugriff (PDF)

Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma

PloS one, 2011-02, Vol.6 (2), p.e16882-e16882

2011

Volltextzugriff (PDF)

Kein Überlebensvorteil beim Sentinel‐Lymphknoten‐positiven Melanom mit sofortiger kompletter Lymphadenektomie – eine Übersicht

Journal der Deutschen Dermatologischen Gesellschaft, 2019-01, Vol.17 (1), p.7

2019

Volltextzugriff (PDF)

1 – 25 von 373

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(340)
Mit Volltextzugriff
(326)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(326)
Deutsch
(53)
Japanisch
(10)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

Micrographic Surgery Allows Fascia Preservation in Dermatofibrosarcoma Protuberans

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome

Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma

Epidemiology of skin cancer

Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma

Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy

Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial

Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour

Neuerungen in der aktualisierten S3-Leitlinie „Aktinische Keratosen und Plattenepithelkarzinom der Haut

Sentinel Lymph Node Dissection in Primary Melanoma Reduces Subsequent Regional Lymph Node Metastasis as Well as Distant Metastasis After Nodal Involvement

A novel role for relaxin-2 in the pathogenesis of primary varicosis

Melanom der Haut – Fakten und Irrtümer: Damit die Haut beim Sonnen nicht Baden geht

Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma

Kein Überlebensvorteil beim Sentinel‐Lymphknoten‐positiven Melanom mit sofortiger kompletter Lymphadenektomie – eine Übersicht

Aktive Filter

Suchergebnisse filtern